PA Medical News about thyroid-associated ophthalmopathy

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ocular surface inflammation, and nerve growth factor level in tears in active thyroid-associated ophthalmopathy
Graefe's Archive for Clinical and Experimental Ophthalmology, 10/26/09

Yoon JS et al. – Tear NGF may have a specific role in ocular surface inflammation, which protects against ocular surface damage in patients with active TAO. Anti–inflammatory treatment significantly reduced the level of NGF in tears, increased tear film stability and production, and decreased congestive symptoms.

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
Thyroid, 10/30/09 Relevance Score: 42%

Co-existence of Euthyroid Graves Ophthalmopathy and Isolated Ocular Myasthenia in a Patient with Vitiligo: A Challenging Diagnosis of Auto-immune Polyglandular Syndrome-3C
Neuro-Ophthalmology, 10/15/09 Relevance Score: 42%

Platelet-derived growth factor-BB: a stimulus for cytokine production by orbital fibroblasts in Graves' Ophthalmopathy
Investigative Ophthalmology and Visual Science, 10/15/09 Relevance Score: 41%

Genetic susceptibility to Graves' ophthalmopathy: the role of polymorphisms in proinflammatory cytokine genes
Eye, 10/07/09 Relevance Score: 40%